MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

MDT

84.7

+0.83%↑

VEEV

231.57

+2.63%↑

A

107.51

+0.6%↑

WBA

10.91

-0.46%↓

CHE

575.22

+1.75%↑

Search

Ekso Bionics Holdings

Open

0.49 6.52

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.44

Max

0.5

Schlüsselkennzahlen

By Trading Economics

Einkommen

-1.3M

-3.4M

Verkäufe

961K

5.1M

EPS

-0.14

Gewinnspanne

-67.053

Angestellte

61

EBITDA

-1.4M

-3M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+880.39% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

904K

12M

Vorheriger Eröffnungskurs

-6.03

Vorheriger Schlusskurs

0.49

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Ekso Bionics Holdings Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

28. Apr. 2025, 23:27 UTC

Top News

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- 2nd Update

28. Apr. 2025, 23:07 UTC

Top News

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- Update

28. Apr. 2025, 23:03 UTC

Ergebnisse

Waste Management 1Q Profit Falls, Revenue Misses Estimates

28. Apr. 2025, 23:47 UTC

Market Talk

Gold Edges Lower as Traders Assess Mixed Signals From Treasury Secretary Bessent -- Market Talk

28. Apr. 2025, 23:17 UTC

Ergebnisse

Jiangxi Copper 1Q Rev CNY111.61B Vs. CNY122.52B >0358.HK

28. Apr. 2025, 23:17 UTC

Ergebnisse

Jiangxi Copper 1Q Net CNY1.95B Vs. Net CNY1.71B >0358.HK

28. Apr. 2025, 23:13 UTC

Ergebnisse

China Merchants Securities: Higher Interest Income, Fee Income Also Aided 1Q Results>600999.SH

28. Apr. 2025, 23:13 UTC

Ergebnisse

China Merchants Securities 1Q Rev CNY4.71B Vs. CNY4.30B >600999.SH

28. Apr. 2025, 23:13 UTC

Ergebnisse

China Merchants Securities: Gains From Investments in Financial Instruments Supported Results >600999.SH

28. Apr. 2025, 23:13 UTC

Ergebnisse

China Merchants Securities 1Q Net CNY2.31B Vs. Net CNY2.16B >600999.SH

28. Apr. 2025, 23:08 UTC

Ergebnisse

China Longyuan Power: 1Q Power Generation Declined 4.42% on Year>0916.HK

28. Apr. 2025, 23:08 UTC

Ergebnisse

China Longyuan Power 1H Rev CNY8.14B Vs. CNY8.07B >0916.HK

28. Apr. 2025, 23:08 UTC

Ergebnisse

China Longyuan Power 1H Net CNY1.98B Vs. Net CNY2.53B >0916.HK

28. Apr. 2025, 23:04 UTC

Ergebnisse

Huaneng Power: 1Q Net Was Mainly Driven By Decline in Domestic Fuel Costs >0902.HK

28. Apr. 2025, 23:04 UTC

Ergebnisse

Huaneng Power: Decrease in Electricity Tariffs Weighed on Rev >0902.HK

28. Apr. 2025, 23:04 UTC

Ergebnisse

Huaneng Power 1Q Rev CNY60.33B ; Down 7.7% on Year>0902.HK

28. Apr. 2025, 23:04 UTC

Ergebnisse

Huaneng Power 1Q Net CNY4.97B; up 8.2% on Year >0902.HK

28. Apr. 2025, 23:00 UTC

Ergebnisse

Jiangsu Expressway 1Q Rev CNY4.78B Vs. CNY3.47B >0177.HK

28. Apr. 2025, 23:00 UTC

Ergebnisse

Jiangsu Expressway: 1Q Rev Rose Due to Increase in Road Construction Projects >0177.HK

28. Apr. 2025, 23:00 UTC

Ergebnisse

Jiangsu Expressway: Decline in Investment Income, Fall in Revenue Post Asset Disposal Weighed on 1Q Net >0177.HK

28. Apr. 2025, 23:00 UTC

Ergebnisse

Jiangsu Expressway 1Q Net CNY1.21B Vs. Net CNY1.25B >0177.HK

28. Apr. 2025, 22:57 UTC

Top News

Trump Signs Order Requiring Nationwide List of Sanctuary Cities and States -- 8th Update

28. Apr. 2025, 22:55 UTC

Ergebnisse

Tsingtao Brewery: Higher Sales Volumes of Beer Supported Results >0168.HK

28. Apr. 2025, 22:55 UTC

Ergebnisse

Tsingtao Brewery 1Q Net CNY1.71B Vs. Net CNY1.60B >0168.HK

28. Apr. 2025, 22:55 UTC

Ergebnisse

Tsingtao Brewery 1Q Rev CNY10.45B Vs. CNY10.15B >0168.HK

28. Apr. 2025, 22:52 UTC

Ergebnisse

S.F. Holding: Results Supported by Higher Contributions From Logistics Business >002352.SZ

28. Apr. 2025, 22:52 UTC

Ergebnisse

S.F. Holding 1Q Net CNY2.23B Vs. Net CNY1.91B >002352.SZ

28. Apr. 2025, 22:52 UTC

Ergebnisse

S.F. Holding: Cost Controls Also aided 1Q Results >002352.SZ

28. Apr. 2025, 22:52 UTC

Ergebnisse

S.F. Holding 1Q Rev CNY69.85B Vs. CNY65.34B >002352.SZ

28. Apr. 2025, 22:46 UTC

Ergebnisse

Shandong Gold Mining: Increase in Selling Price of Gold Supported Results>600547.SH

Peer-Vergleich

Kursveränderung

Ekso Bionics Holdings Prognose

Kursziel

By TipRanks

880.39% Vorteil

12-Monats-Prognose

Durchschnitt 5 USD  880.39%

Hoch 9 USD

Tief 1 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Ekso Bionics Holdings – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

2

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

0.42899 / N/AUnterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Very Strong Bullish Evidence

Langfristig

No Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Ekso Bionics Holdings

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.